Personalis, Inc. (PSNL)
Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or plasma sample; ImmunoID Next for tumor profiling from tissue; NeXT Liquid Biopsy for tumor profiling from plasma; NeXT Personal, a liquid biopsy offering for personalized tumor tracking for patients; NeXT Dx Test, a genomic cancer profiling test enabling composite biomarkers for cancer treatment; and NeXT SHERPA and NeXT NEOPS for neoantigen prediction capabilities. The company also provides ACE platform for clinical and therapeutic applications such as neoantigen prediction, biomarker identification, and novel drug target selection. It serves biopharmaceutical customers, universities, non-profits, and government entities. The company has partnership with Mayo Clinic; MapKure, LLC; SpringWorks Therapeutics, Inc.; and Moores Cancer Center. Personalis, Inc. was incorporated in 2011 and is headquartered in Menlo Park, California.
$241.49M
Mr. Aaron L. Tachibana
325.00
Menlo Park, CA
Jun 20, 2019
-3.58
$-1.27
3.40
5.63
-164.10%
-0.63
0.40
1.06
5.15
-44.24%
-53.08%
Similar stocks (11)
Illumina, Inc.
ILMN
Natera, Inc.
NTRA
Charles River Laboratories International, Inc.
CRL
Guardant Health, Inc.
GH
Twist Bioscience Corporation
TWST
Myriad Genetics, Inc.
MYGN
CareDx, Inc
CDNA
Castle Biosciences, Inc.
CSTL
Sera Prognostics, Inc.
SERA
Neuronetics, Inc.
STIM
DarioHealth Corp.
DRIO
ETF Exposure (14)
ARK Genomic Revolution ETF
ARKG
3.06%
Dimensional U.S. Small Cap ETF
DFAS
0.0019841900000000003%
Dimensional US Sustainability Core 1 ETF
DFSU
0.00194145%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.8703e-4%
Dimensional US Core Equity Market ETF
DFAU
1.4087e-4%
Dimensional U.S. Equity ETF
DFUS
1.0619999999999999e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (11)
Illumina, Inc.
ILMN
Natera, Inc.
NTRA
Charles River Laboratories International, Inc.
CRL
Guardant Health, Inc.
GH
Twist Bioscience Corporation
TWST
Myriad Genetics, Inc.
MYGN
CareDx, Inc
CDNA
Castle Biosciences, Inc.
CSTL
Sera Prognostics, Inc.
SERA
Neuronetics, Inc.
STIM
DarioHealth Corp.
DRIO
ETF Exposure (14)
ARK Genomic Revolution ETF
ARKG
3.06%
Dimensional U.S. Small Cap ETF
DFAS
0.0019841900000000003%
Dimensional US Sustainability Core 1 ETF
DFSU
0.00194145%
Dimensional U.S. Core Equity 2 ETF
DFAC
3.8703e-4%
Dimensional US Core Equity Market ETF
DFAU
1.4087e-4%
Dimensional U.S. Equity ETF
DFUS
1.0619999999999999e-4%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%